William Hagopian at the Pacific Northwest Research Institute began Phase I of the hOKT3 study
In 2003, Dr. William Hagopian at the Pacific Northwest Research Institute began Phase I of the hOKT3 study.
William Hagopian, M.D., Ph.D., served as PNDRI’s Scientific Director and focused on research strategies in immunology and molecular biology for predicting and preventing type 1 diabetes before clinical disease onset.
Tags:
Source: National Library of Medicine
Credit:
